ReviewDiabetes, obesity & metabolism2022

Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitors.

Gian Paolo Fadini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.